Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High?

Shares of Tango Therapeutics, Inc. (TNGX) have gained 18.2% over the past four weeks to close the last trading session at $8.9, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13 indicates a potential upside of 46.1%.The mean estimate comprises eight short-term price targets with a standard deviation of $1.31. While the lowest estimate of $11.00 indicates a 23.6% increase from ...